| Year |
Citation |
Score |
| 2022 |
Tsui CKM, Sorrentino F, Narula G, Mendoza-Losana A, Del Rio RG, Herrán EP, Lopez A, Bojang A, Zheng X, Remuiñán-Blanco MJ, Av-Gay Y. Hit Compounds and Associated Targets in Intracellular . Molecules (Basel, Switzerland). 27. PMID 35889319 DOI: 10.3390/molecules27144446 |
0.503 |
|
| 2020 |
L Moure A, Narula G, Sorrentino F, Bojang A, K M Tsui C, Sao Emani C, Porras-De Francisco E, Diaz B, Rebollo-Lopez MJ, Torres Gómez PA, Lopez-Roman EM, Camino I, Casado Castro P, Guijarro López L, Ortega F, et al. A MymA bioactivated thioalkyl-benzoxazole prodrug family active against Mycobacterium tuberculosis. Journal of Medicinal Chemistry. PMID 32275415 DOI: 10.1021/Acs.Jmedchem.0C00003 |
0.547 |
|
| 2015 |
Sorrentino F, Gonzalez Del Rio R, Zheng X, Presa JM, Torres Gomez P, Martinez Hoyos M, Perez Herran ME, Mendoza Losana A, Av-Gay Y. Development of an intracellular screen for new compounds able to inhibit Mycobacterium tuberculosis growth in human macrophages. Antimicrobial Agents and Chemotherapy. PMID 26503663 DOI: 10.1128/Aac.01920-15 |
0.497 |
|
| 2012 |
La Rosa V, Poce G, Canseco JO, Buroni S, Pasca MR, Biava M, Raju RM, Porretta GC, Alfonso S, Battilocchio C, Javid B, Sorrentino F, Ioerger TR, Sacchettini JC, Manetti F, et al. MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212. Antimicrobial Agents and Chemotherapy. 56: 324-31. PMID 22024828 DOI: 10.1128/Aac.05270-11 |
0.397 |
|
| Show low-probability matches. |